Quick Takeaways
- This page summarizes PATRICK DEVAL L's Form 4 filing for Global Blood Therapeutics, Inc..
- 4 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 16 Jun 2022, 18:00.
PATRICK DEVAL L - 14 Jun 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.
- Role
- Director
- Signature
- /s/ Miguel Carrillo, Attorney-in-Fact
- Issuer symbol
- N/A
- Transactions as of
- 14 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 16 Jun 2022, 18:00:16 UTC
- Previous filing
- 15 Jun 2022
- Next filing
- 17 Jun 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"PATRICK DEVAL L filed Form 4 for Global Blood Therapeutics, Inc. on 16 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 15 Jun 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
GBT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,600
- Change %
- +66%
- Price
- Shares after
- 9,037
- Date
- 14 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
GBT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,600
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,600
- Exercise price
- Footnotes
- F1, F2
GBT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +5,600
- Change %
- Price
- $0.000000
- Shares after
- 5,600
- Date
- 14 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,600
- Exercise price
- $22.30
- Footnotes
- F3
GBT
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +3,600
- Change %
- Price
- $0.000000
- Shares after
- 3,600
- Date
- 14 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,600
- Exercise price
- Footnotes
- F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| F2 | The RSUs vested in a single installment on June 14, 2022. |
| F3 | The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 14, 2022 for 11 months and the remaining 1/12th on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended). |
| F4 | The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended). |